Prostate cancer is the most common non-cutaneous cancer in men in the United States.
Cancer metabolism has emerged as a contemporary topic of great interest for improved …

Prostate cancer (PCa) is one of the most frequently diagnosed cancers and a leading cause
of death among men worldwide. Despite extensive efforts in biomarker discovery during the …

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are
inflammatory diseases of the central nervous system. Although several studies have …

There is a great interest in searching for diagnostic biomarkers in prostate cancer patients.
The aim of the pilot study was to evaluate free amino acid profiles in their serum and urine …

Nuclear magnetic resonance (NMR) is a rapid and accurate analytical tool for qualification
and quantification. The capacity of NMR of being quantitative can also justify the calibration …

Understanding the metabolism of prostate cancer (PCa) is important for developing better
diagnostic approaches and also for exploring new therapeutic targets. Magnetic resonance …

Background: Robust biomarkers that identify prostate cancer patients with high risk of
recurrence will improve personalised cancer care. In this study, we investigated whether …

Abstract Introduction Prostate cancer (PCa) is one of the most prevalent cancers in men
worldwide. Serum prostate-specific antigen (PSA) remains the most used biomarker in the …

Prostate cancer (PCa) is the most commonly diagnosed cancer in male individuals,
principally affecting men over 50 years old, and is the leading cause of cancer-related …

Prostate cancer (PCa) is the second most common male cancer worldwide and the fifth
leading cause of death from cancer in men. Early detection and risk stratification is the most …